Robert Haile to Follow-Up Studies
This is a "connection" page, showing publications Robert Haile has written about Follow-Up Studies.
Connection Strength
0.362
-
Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial. Am J Clin Nutr. 2019 10 01; 110(4):903-911.
Score: 0.026
-
Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer. 2018 11 01; 143(9):2250-2260.
Score: 0.024
-
Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol. 2018 Mar 01; 4(3):317-323.
Score: 0.023
-
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 06; 108:140-149.
Score: 0.022
-
Childhood cancers in families with and without Lynch syndrome. Fam Cancer. 2015 Dec; 14(4):545-51.
Score: 0.020
-
Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Fam Cancer. 2015 Dec; 14(4):575-83.
Score: 0.020
-
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):68-75.
Score: 0.020
-
Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden. Breast Cancer Res Treat. 2015 Nov; 154(2):369-75.
Score: 0.020
-
Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control. 2013 Aug; 24(8):1605-14.
Score: 0.017
-
Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):681-4.
Score: 0.015
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
Score: 0.015
-
Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study. Nutr Cancer. 2012; 64(7):899-910.
Score: 0.015
-
Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila). 2010 Dec; 3(12):1552-64.
Score: 0.014
-
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010 Aug; 19(8):2023-34.
Score: 0.014
-
Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009 Jul 21; 151(2):103-9.
Score: 0.013
-
Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev. 2009 Apr; 18(4):1041-9.
Score: 0.012
-
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst. 2009 Mar 18; 101(6):432-5.
Score: 0.012
-
Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst. 2009 Feb 18; 101(4):267-76.
Score: 0.012
-
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9.
Score: 0.011
-
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst. 2007 Jan 17; 99(2):129-36.
Score: 0.011
-
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul; 129(1):34-41.
Score: 0.010
-
Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16; 96(12):921-5.
Score: 0.009
-
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 06; 348(10):891-9.
Score: 0.008